|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 EUR | +0.68% |
|
+4.23% | +23.33% |
| Mar. 29 | Evrofarma SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Evrofarma SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Evrofarma SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 45.38 million compared to EUR 36.7 million a year ago. Net income was EUR 1.42 million compared to net loss of EUR 0.355 million a year ago.
Basic earnings per share from continuing operations was EUR 0.1038 compared to basic loss per share from continuing operations of EUR 0.026 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.33% | 21.47M | |
| -3.66% | 22.69B | |
| +1.69% | 7.41B | |
| -31.81% | 7.38B | |
| +3.32% | 6.05B | |
| -3.40% | 5.35B | |
| -1.98% | 5.32B | |
| +22.74% | 5.06B | |
| -15.22% | 4.31B | |
| -0.28% | 3.72B |
EVROFARMA SA 
